FOLR1 and neoplasm: After 2 doses of chemotherapy, folate receptor alpha levels remained stable in most of the patients however, some declines were recorded. There was also a 71% concordance rate between archival tumor biopsy samples and pretreatment biopsy samples in the levels of folate receptor alpha in eligible patients.